Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
03 janv. 2019 08h30 HE
|
Cocrystal Pharma, Inc.
BOTHELL, WA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel...